Delibera n.2023/1811 Sottosccrizione dell'Addendum II allo studio clinico "A Phase III, randomized, double-blind, placebocontrolled multicountry study to demostrate efficacy of a single dose of unadjuvanted RSV Maternal vaccine, administered IM to pregnant women 18 to 49 years of age, for prevention of RSV associated LRTI in their infants up to 6 months of age... Dott. salvino Marcello VITALITI Direttore della stessa UOC (Prop. 77)
 20231811.pdf | [ ] | 3375 kB | 2023-12-12 11:12 | 2023-12-12 11:12 |